Skip to main content
PFSA
NASDAQ Industrial Applications And Services

Profusa Announces 1-for-25 Reverse Stock Split Amidst Delisting Threats, Enabling Extreme Dilution

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$0.109
Mkt Cap
$531.27K
52W Low
$0.08
52W High
$957.003
52W Position info
36% above low
Off High info
100% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

PFSA sits 36% above its 52-week low of $0.08.

Summary

Profusa will enact a 1-for-25 reverse stock split on July 7, 2026, to maintain its Nasdaq listing, but the resulting share structure allows for over 113,000% potential dilution.


Key Events · Corporate Governance and Compliance · PFSA

  • 1-for-25 Reverse Stock Split Effective

    Profusa, Inc. will implement a 1-for-25 reverse stock split, effective July 7, 2026, following shareholder approval on June 23, 2026. The stock will trade on a post-split basis under the existing ticker symbol PFSA.

  • Nasdaq Listing Compliance

    This reverse split is a critical action to help the company meet Nasdaq's minimum bid price requirements, coming after a delisting notice in April 2026 and a subsequent exception granted by the Nasdaq Hearings Panel.

  • Extreme Potential Dilution

    Post-split, outstanding shares will be reduced to approximately 530,000, but the number of authorized shares will remain at 601 million. If all authorized shares were issued, potential dilution would exceed 113,000%.

  • Financial Distress Context

    The reverse split occurs amidst significant financial challenges, including a going concern warning, zero revenue, and increased losses reported in the company's recent 10-K and 10-Q filings.


Analysis · PFSA · Industrial Applications And Services

This 8-K announces the execution of a 1-for-25 reverse stock split, a critical move for Profusa to regain compliance with Nasdaq's minimum bid price requirement following a prior delisting notice. While necessary for continued listing, the decision to keep authorized shares at 601 million post-split, with only 530,000 outstanding, creates an extreme potential for future dilution (over 113,000%). This structure allows the company to raise substantial capital through future share issuances, but at a potentially devastating cost to existing shareholders, especially given the company's ongoing financial distress and going concern warning.

At the time of this filing, PFSA was trading at $0.11 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $531.3K. The 52-week trading range was $0.08 to $957.00. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

PFSA - Latest Insights

PFSA
Jul 31, 2026, 5:15 PM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $0.860
Real-time Price: $0.9445 info
Change: +$0.0845 (+10%) info
Market Cap: $510.284K info
PFSA
Jul 31, 2026, 4:56 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.870
Real-time Price: $0.9445 info
Change: +$0.0745 (+9%) info
Market Cap: $510.284K info
PFSA
Jul 27, 2026, 6:08 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.57
Real-time Price: $0.9445 info
Change: -$0.6255 (-40%) info
Market Cap: $510.284K info
PFSA
Jul 27, 2026, 6:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $1.64
Real-time Price: $0.9445 info
Change: -$0.6955 (-42%) info
Market Cap: $510.284K info
PFSA
Jul 07, 2026, 8:52 AM EDT
Filing Type: 424B3
Importance Score:
8
Price at Filing: $0.088
Real-time Price: $0.9445 info
Change: Reverse Stock Split info
Market Cap: $510.284K info